Tenderwize
Wróć do wyszukiwania

Open house Arzneimittelrabattverträge zum Wirkstoff Zidovudin und Lamivudin, ATC J05AR01

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 218 days left·Open·Supplies
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Zidovudin und Lamivudin, ATC J05AR01

30/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

30 / 100

Złożoność

20 / 100

Czynniki ryzyka

The buyer reserves the right to replace open house contracts with exclusive contracts from tenders at any time, resulti...

No estimated value, minimum volume, or discount rate is disclosed. The actual business volume is uncertain.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of pharmaceutical products containing the active substances Zidovudin and Lamivudin (ATC J05AR01) for the German market.
  • Participation in a non-exclusive open house discount agreement scheme.
Pokaż pełne podsumowanie

Open house model for non-exclusive discount agreements on pharmaceuticals with active substances Zidovudin and Lamivudin (ATC J05AR01). The AOK Rheinland-Pfalz/Saarland invites all interested pharmaceutical companies to conclude uniform discount contracts without a competitive award procedure. Contracts run for a maximum of 24 months from June 2025, with rolling entry possible at the start of each month. The buyer may replace these agreements with exclusive contracts via tenders. No estimated value or award criteria are specified. This is not a public procurement under EU directive 2014/24.

Ryzyka

The buyer reserves the right to replace open house contracts with exclusive contracts from tenders at any time, resulti...

No estimated value, minimum volume, or discount rate is disclosed. The actual business volume is uncertain.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Pharmaceutical products must be authorized and marketable in Germany.
  • Proof of marketability via Lauer-Taxe listing or AMIce database extract.

Administrative

  • Submission of signed contract documents before each desired start date.

Zamawiający

Lokalizacja

Eisenberg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE271900642

Działalność

Health

Części (1)

LOT-0001

Open house Arzneimittelrabattverträge zum Wirkstoff Zidovudin und Lamivudin, ATC J05AR01

Non-exclusive discount agreements for pharmaceuticals containing Zidovudin and Lamivudin. Uniform terms for all participants. All licensed pharmaceutical companies with marketable products in Germany can join. Contracts start at the earliest on 01.06.2025 and end at the latest on 31.05.2027. Rolling entry possible on the 1st of each month with submission by end of the month preceding the desired start month.

SuppliesEU fundedElectronic submission

Lokalizacja

Eisenberg, Germany

Czas trwania

May 2025 - May 2027

Kategoria

Pharmaceutical products

Termin

Deadline Mar 31, 2027

Szczegóły zamówienia

Data publikacji
10 Apr 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
237769-2025

Dokumenty (1)

Podobne przetargi